Priority Date: 08.02.12 (EP 20120154554)

EX VIVO NK CELL DIFFERENTIATION FROM CD34+ HEMATOPOIETIC CELLS

  • Application ID: EP13709575
  • Status: GRANT OF PATENT INTENDED

Applicant

Technology company logo small
Technology Company

Attorney

operating since 1916
Headquarter in The Hague and 9 offices
active in Legal Services and IP Consulting

Specialization

This patent has the IPC combination A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) and C12 (BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING) Vereenigde Octrooibureaux NV (V.O.) is specialized in the combination A61 and C12. We found, that TransMIT GmbH, Kailuweit & Uhlemann, Sperling Fischer & Heyner, Zacco Denmark A/S, Lederer Keller Patentanwälte Partnerschaft mbB and 173 others are specialized in all of these IPC classes as well. For a similar patent, they might be a good choice.

Timeline

  • 08.02.2012 - Priority Date (EP 20120154554)
  • 15.08.2013 - Publication A1 (WO2013119118)
  • 17.12.2014 - Publication A1 (EP2812011)

IPC Classification